Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Laryngol Otol ; 123(11): 1271-5, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19152726

ABSTRACT

BACKGROUND: Adenosquamous carcinoma is a very rare tumour which is characterised pathologically by the simultaneous presence of distinct areas of adenocarcinoma and squamous cell carcinoma. Generally, adenosquamous carcinoma has an aggressive clinical course and is associated with a poor prognosis. Most cases have been treated by surgery alone or combined with radiotherapy. Chemotherapy is rarely used in treating adenosquamous carcinoma, and it has been difficult to establish treatment guidelines due to the paucity of cases. CASE: We report a case of adenosquamous carcinoma which arose in the maxillary sinus of a 77-year-old man. Despite surgical treatment and chemoradiotherapy to the primary site, he developed bilateral neck metastases after the surgery. The patient was treated with S-1, a novel oral fluoropyrimidine anticancer agent, with a complete (albeit finite) response. CONCLUSION: This report presents the aggressive character of adenosquamous carcinoma and the possible role of S-1 in the treatment of this uncommon neoplasm.


Subject(s)
Antimetabolites, Antineoplastic/therapeutic use , Antineoplastic Combined Chemotherapy Protocols , Carcinoma, Adenosquamous/drug therapy , Maxillary Sinus Neoplasms/drug therapy , Oxonic Acid/therapeutic use , Tegafur/therapeutic use , Aged , Carcinoma, Adenosquamous/diagnosis , Carcinoma, Adenosquamous/surgery , Drug Combinations , Humans , Lymphatic Metastasis , Male , Maxillary Sinus Neoplasms/diagnosis , Maxillary Sinus Neoplasms/surgery , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...